|
ZNF124 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.244500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.927600E-01 |
| Normal-vs-Stage2 |
7.052600E-01 |
| Normal-vs-Stage3 |
2.118700E-03 |
| Normal-vs-Stage4 |
1.611130E-04 |
| Stage1-vs-Stage2 |
6.584600E-01 |
| Stage1-vs-Stage3 |
3.841300E-03 |
| Stage1-vs-Stage4 |
1.759100E-04 |
| Stage2-vs-Stage3 |
5.558300E-02 |
| Stage2-vs-Stage4 |
1.867770E-02 |
| Stage3-vs-Stage4 |
4.004400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.310000E-02 |
| Normal-vs-AfricanAmerican |
4.703900E-02 |
| Normal-vs-Asian |
5.175200E-01 |
| Caucasian-vs-AfricanAmerican |
2.755600E-01 |
| Caucasian-vs-Asian |
3.933800E-01 |
| AfricanAmerican-vs-Asian |
3.011800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.157800E-02 |
| Normal-vs-Female |
6.310600E-01 |
| Male-vs-Female |
9.683900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.167890E-02 |
| Normal-vs-Age(41-60Yrs) |
6.198000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.119500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.463000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.054400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.089800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.748400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.036630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.358600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.258200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.580800E-01 |
| Normal-vs-Grade 2 |
8.160400E-01 |
| Normal-vs-Grade 3 |
5.049600E-02 |
| Normal-vs-Grade 4 |
3.18389999998114E-06 |
| Grade 1-vs-Grade 2 |
3.788000E-01 |
| Grade 1-vs-Grade 3 |
6.051700E-02 |
| Grade 1-vs-Grade 4 |
1.417760E-03 |
| Grade 2-vs-Grade 3 |
3.826100E-02 |
| Grade 2-vs-Grade 4 |
2.66049999997353E-06 |
| Grade 3-vs-Grade 4 |
2.444500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.373800E-02 |
| Normal-vs-ccB subtype |
1.769810E-04 |
| ccA subtype-vs-ccB subtype |
8.59869997427154E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.486400E-01 |
| Normal-vs-N1 |
5.133800E-01 |
| N0-vs-N1 |
7.737600E-01 |
|
|
